We post reviews for MSK healthcare providers who have at least 30 patient experience surveys completed. If you do not see reviews for a provider, it may be because they do not yet have enough survey responses, or the provider may not be part of the group of healthcare providers included in the survey.
Only outpatient providers are included in the survey. Healthcare providers who only work in the hospital or in urgent care are not included in the survey. Pathologists or researchers who do not provide direct care to patients do not have reviews.
I am a radiation oncologist specializing in the use of image-guided radiotherapy for the treatment of spine tumors. This treatment utilizes intensity-modulated radiotherapy and stereotactic radiosurgery techniques to deliver safe and effective radiation to tumors of the spine. I work closely with an interdisciplinary team of surgeons, medical physicists, radiologists, and nurses to provide high-quality, personalized treatment for each patient.
Read more
I am also the principal investigator of a laboratory that aims to understand the role of noncoding elements of the genome in cancer. We are just beginning to appreciate how these components of the genome are frequently mutated in cancer in ways that can significantly impact cellular physiology. We believe that characterizing the function of these elements will provide important insights into cancer development and behavior that may ultimately lead to improved cancer therapy.
My Role at MSK
A radiation oncologist is a cancer doctor with special training in using radiation therapy (RT) to treat cancer with radiation.
Areas of Expertise
Conditions I Treat
Spinal tumors
My Specialties
Stereotactic body radiation therapy (SBRT)
Image-Guided Radiation Therapy (IGRT)
Intensity-Modulated Radiation Therapy (IMRT)
Education & Honors
Education
MD, University of Chicago
Residencies
Stanford University
Board Certifications
Radiation Oncology
Insurance Information
Understanding your insurance options is an important part of managing your cancer care. We have relationships with many common healthcare providers and plans.
Aetna
In Network Coverage Type HMO, EPO PPO, POS, Transplant
Request an appointment by logging on to MyMSK or calling your doctor’s office. If you aren’t registered for MyMSK, call 646-227-2593 for your Enrollment ID.
Doctors at Memorial Sloan Kettering work as teams, with specialists from all different areas. This allows us to consider all your needs together, and to give you the best possible care.
Memorial Sloan Kettering's doctors and scientists are constantly developing new treatments for cancer. MSK is typically running hundreds of clinical trials at a given time.
You may be able to participate in a clinical trial even if you are new to MSK. Search our online directory to find trial information and see more about who can participate.
Visit PubMed for a full listing of Dr. Schmitt’s journal articles. Pubmed is an online index of research papers and other articles from the US National Library of Medicine and the National Institutes of Health.
We strive to keep reviews trustworthy, honest and fair.
Learn more about our patient experience reviews.
Disclosures
Doctors and faculty members often work with pharmaceutical, device, biotechnology, and life sciences companies, and other organizations outside of MSK, to find safe and effective cancer treatments, to improve patient care, and to educate the health care community.
MSK requires doctors and faculty members to report (“disclose”) the relationships and financial interests they have with external entities. As a commitment to transparency with our community, we make that information available to the public.
Adam Schmitt discloses the following relationships and financial interests:
Arinale Biosciences Equity; Fiduciary Role / Position; Intellectual Property Rights
If you’re a patient at MSK and would like more information about your doctor’s external relationships, please talk with your doctor.
The information published here is a complement to other publicly reported data and is for a specific annual disclosure period. There may be differences between information on this and other public sites as a result of different reporting periods and/or the various ways relationships and financial interests are categorized by organizations that publish such data.
This page and data include information for a specific MSK annual disclosure period (January 1, 2023 through disclosure submission in spring 2024). This data reflects interests that may or may not still exist. This data is updated annually.
Learn more about MSK’s COI policies here. For questions regarding MSK’s COI-related policies and procedures, email MSK’s Compliance Office at [email protected].